|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/02 | |
| A61K 39/00 | |||
| A61K 39/39 | |||
| A61K 47/50 | |||
| A61K 47/64 |
| (11) | Patento numeris | 2519265 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10818096.9 |
| Europos patento paraiškos padavimo data | 2010-12-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-11-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2010/003484 |
| Data | 2010-12-30 |
| (87) | Numeris | WO 2011/080595 |
| Data | 2011-07-07 |
| (30) | Numeris | Data | Šalis |
| 291262 P | 2009-12-30 | US |
| (72) |
COSTANTINO, Paolo, IT
SERINO, Laura, IT
ROMANO, Maria Rosaria, IT
TONTINI, Marta, IT
BERTI, Francesco, IT
MICOLI, Francesca, IT
KABANOVA, Anna, IT
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | POLYSACCHARIDE IMMUNOGENS CONJUGATED TO E. COLI CARRIER PROTEINS |
| POLYSACCHARIDE IMMUNOGENS CONJUGATED TO E. COLI CARRIER PROTEINS |